These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33067170)

  • 1. Influence of aspirin use on clinical outcomes of patients with hepatocellular carcinoma: a meta-analysis.
    Li X; Yu Y; Liu L
    Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101545. PubMed ID: 33067170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin use and the prognosis of patients with hepatocellular carcinoma: a meta-analysis.
    Li X; Liu L; Hu Y
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32162652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review with meta-analysis: The effects of non-steroidal anti-inflammatory drugs and anti-platelet therapy on the incidence and recurrence of hepatocellular carcinoma.
    Tan RZH; Lockart I; Abdel Shaheed C; Danta M
    Aliment Pharmacol Ther; 2021 Aug; 54(4):356-367. PubMed ID: 34247393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
    Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
    Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does aspirin reduce the incidence, recurrence, and mortality of hepatocellular carcinoma? A GRADE-assessed systematic review and dose-response meta-analysis.
    Ma S; Qu G; Sun C; Liu H; Jiang Y; Li N; Wu B; Gao J; Feng L; Xie P; Xia W; Kim NH; Lowe S; Bentley R; Zhu Y; Zhou Q; Sun Y
    Eur J Clin Pharmacol; 2023 Jan; 79(1):39-61. PubMed ID: 36334108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin Use and the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B Virus or Hepatitis C Virus Infection: A Meta-Analysis of Cohort Studies.
    Li X; Wu S; Yu Y
    Front Med (Lausanne); 2020; 7():569759. PubMed ID: 33490093
    [No Abstract]   [Full Text] [Related]  

  • 7. Aspirin Use and the Risk of Hepatocellular Carcinoma: A Meta-analysis.
    Wang Y; Wang M; Liu C; Wang W; Shi J; Dang S
    J Clin Gastroenterol; 2022 Aug; 56(7):e293-e302. PubMed ID: 35316225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regular Aspirin Use Is Associated with a Reduced Risk of Hepatocellular Carcinoma (HCC) in Chronic Liver Disease: a Systematic Review and Meta-analysis.
    Tan JL; Sidhu-Brar S; Woodman R; Chinnaratha MA
    J Gastrointest Cancer; 2023 Jun; 54(2):325-331. PubMed ID: 35717551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin Use Is Associated with a Reduced Incidence of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Memel ZN; Arvind A; Moninuola O; Philpotts L; Chung RT; Corey KE; Simon TG
    Hepatol Commun; 2021 Jan; 5(1):133-143. PubMed ID: 33437907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.
    Zeng RW; Yong JN; Tan DJH; Fu CE; Lim WH; Xiao J; Chan KE; Tan C; Goh XL; Chee D; Syn N; Tan EX; Muthiah MD; Ng CH; Tamaki N; Lee SW; Kim BK; Nguyen MH; Loomba R; Huang DQ
    Aliment Pharmacol Ther; 2023 Mar; 57(6):600-609. PubMed ID: 36625733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin Use and Mortality in Women With Ovarian Cancer: A Meta-Analysis.
    Man X; Wang B; Tan Y; Yang X; Zhang S
    Front Oncol; 2020; 10():575831. PubMed ID: 33598421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between aspirin consumption and hepatocellular carcinoma: a systematic review and meta-analysis.
    Wang S; Zuo L; Lin Z; Yang Z; Chen R; Xu Y
    Eur J Med Res; 2023 Jul; 28(1):226. PubMed ID: 37422691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin in Patients with Viral Hepatitis: Systematic Review and Meta-Analysis of Observational Studies.
    Bian W; Bian W; Li Q; Li Y
    J Gastrointest Cancer; 2024 Jun; 55(2):638-651. PubMed ID: 38557825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin for the prevention of hepatocellular carcinoma: an updated meta-analysis with particular focus on patients with chronic liver disease.
    Yi M; Feng X; Peng W; Teng F; Tang Y; Chen Z
    Eur J Clin Pharmacol; 2022 Apr; 78(4):647-656. PubMed ID: 35032181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
    Lee TY; Hsu YC; Tseng HC; Yu SH; Lin JT; Wu MS; Wu CY
    JAMA Intern Med; 2019 May; 179(5):633-640. PubMed ID: 30882847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies.
    Yang WS; Va P; Bray F; Gao S; Gao J; Li HL; Xiang YB
    PLoS One; 2011; 6(12):e27326. PubMed ID: 22205924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Review and Meta-analysis: Association of Aspirin With Incidence of Hepatocellular Carcinoma.
    Zhou X; Zhang T; Sun Y; Li C; Ding X; Zhu Y; Li L; Fan Z
    Front Pharmacol; 2022; 13():764854. PubMed ID: 35300300
    [No Abstract]   [Full Text] [Related]  

  • 18. A meta-analysis and systematic review: adjuvant interferon therapy for patients with viral hepatitis-related hepatocellular carcinoma.
    Jiang S; Liu Y; Wang L; Duan C; Liu M
    World J Surg Oncol; 2013 Sep; 11():240. PubMed ID: 24060218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsteroidal anti-inflammatory drugs, especially aspirin, are linked to lower risk and better survival of hepatocellular carcinoma: a meta-analysis.
    Tao Y; Li Y; Liu X; Deng Q; Yu Y; Yang Z
    Cancer Manag Res; 2018; 10():2695-2709. PubMed ID: 30147368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants.
    Wang S; Yu Y; Ryan PM; Dang M; Clark C; Kontogiannis V; Rahmani J; Varkaneh HK; Salehisahlabadi A; Day AS; Zhang Y
    Pharmacol Res; 2020 Jan; 151():104585. PubMed ID: 31816436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.